Xenotransplantation is a medical procedure involving the transplantation of organs, tissues, or cells from one species to another, with a notable focus on utilizing pig organs for human transplantation. Pigs are often chosen due to physiological similarities with humans and the availability of large, genetically modified pig herds for xenotransplantation purposes. This innovative approach seeks to address the shortage of human donor organs for transplantation, a significant global healthcare challenge. However, xenotransplantation faces substantial immunological barriers, particularly the risk of hyperacute rejection, where the recipient's immune system rapidly attacks the xenograft. Researchers have employed genetic engineering to modify pigs to reduce immunological incompatibilities and mitigate the risk of rejection. The potential success of xenotransplantation could revolutionize organ transplantation, offering a more abundant and readily available source of organs. Ethical and safety concerns, including the risk of zoonotic infections and long-term consequences, must be thoroughly addressed before widespread clinical implementation. Ongoing research aims to refine xenotransplantation techniques, enhance the compatibility of pig organs with the human immune system, and establish comprehensive regulatory frameworks to ensure the safety and ethical considerations of this promising medical frontier.
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : AI-integrated high-throughput tissue-chip for brain aging
Kunal Mitra, Florida Tech, United States
Title : Assembly and stability of on-chip microvasculature
Kara E McCloskey, University of California, Merced, United States
Title : Bioengineering human cornea for global supply
Jingjing You, University of Sydney, Australia